iSAM Funds UK Ltd purchased a new stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 12,604 shares of the company’s stock, valued at approximately $1,308,000. Colgate-Palmolive makes up approximately 0.7% of iSAM Funds UK Ltd’s portfolio, making the stock its 28th largest position.
Other institutional investors and hedge funds have also modified their holdings of the company. Continuum Advisory LLC boosted its position in Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after purchasing an additional 125 shares during the last quarter. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at about $42,000. Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive in the third quarter valued at approximately $53,000. Prospera Private Wealth LLC acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth $64,000. Finally, Gradient Investments LLC increased its stake in shares of Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after purchasing an additional 400 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.34% of the company’s stock.
Wall Street Analyst Weigh In
Read Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Price Performance
Shares of Colgate-Palmolive stock opened at $94.23 on Friday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a fifty-two week low of $75.50 and a fifty-two week high of $109.30. The firm has a fifty day moving average price of $96.73 and a two-hundred day moving average price of $98.61. The company has a market cap of $76.99 billion, a PE ratio of 27.00, a price-to-earnings-growth ratio of 3.38 and a beta of 0.43.
Colgate-Palmolive Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.12%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- 5 Top Rated Dividend Stocks to Consider
- Archer or Joby: Which Aviation Company Might Rise Fastest?
- About the Markup Calculator
- Nebius Group Stock: A Rising AI Infrastructure Star
- Insider Buying Explained: What Investors Need to Know
- Celsius Stock May Thrive as Pepsi and Coca-Cola Face Headwinds
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.